|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-3-22
|
|
pubmed:abstractText |
Transient receptor potential vanilloid type 1 (TRPV1) is a cation channel activated by diverse obnoxious stimuli like capsaicin, low pH or heat. Recently, it was revealed that TRPV1 might be deeply associated with skin permeability barrier function, suggesting that modulation of TRPV1 might be beneficial for the skin disorders with barrier damages.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acrylamides,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Capsaicin,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin E,
http://linkedlifedata.com/resource/pubmed/chemical/Intermediate Filament Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oxazolone,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/TRPV Cation Channels,
http://linkedlifedata.com/resource/pubmed/chemical/TRPV1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/TRPV1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/filaggrin,
http://linkedlifedata.com/resource/pubmed/chemical/loricrin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1873-569X
|
|
pubmed:author |
pubmed-author:BaeIl-HongIH,
pubmed-author:JangWon-HeeWH,
pubmed-author:JeongYeon SuYS,
pubmed-author:KimSun-YoungSY,
pubmed-author:LeeJihaeJ,
pubmed-author:LeeKi-WhaKW,
pubmed-author:LimKyung-MinKM,
pubmed-author:ParkYoung-HoYH,
pubmed-author:SeoJung AJA,
pubmed-author:ShinSong-SeokSS,
pubmed-author:WooByoung-YoungBY,
pubmed-author:YunJun-WonJW
|
|
pubmed:copyrightInfo |
Copyright © 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
8-15
|
|
pubmed:meshHeading |
pubmed-meshheading:21345654-Acrylamides,
pubmed-meshheading:21345654-Animals,
pubmed-meshheading:21345654-Calcium,
pubmed-meshheading:21345654-Capsaicin,
pubmed-meshheading:21345654-Dermatitis,
pubmed-meshheading:21345654-Dermatitis, Atopic,
pubmed-meshheading:21345654-Female,
pubmed-meshheading:21345654-Humans,
pubmed-meshheading:21345654-Immunoglobulin E,
pubmed-meshheading:21345654-Intermediate Filament Proteins,
pubmed-meshheading:21345654-Lipids,
pubmed-meshheading:21345654-Mast Cells,
pubmed-meshheading:21345654-Membrane Proteins,
pubmed-meshheading:21345654-Mice,
pubmed-meshheading:21345654-Oxazolone,
pubmed-meshheading:21345654-Perfusion,
pubmed-meshheading:21345654-Permeability,
pubmed-meshheading:21345654-Pyridines,
pubmed-meshheading:21345654-Skin,
pubmed-meshheading:21345654-TRPV Cation Channels
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery.
|
|
pubmed:affiliation |
Pharmaceutical Research Institute, Amorepacific Corporation R&D Center, 314-1, Bora-dong, Giheung-gu, Yongin 446-729, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
